Peter E. Boyd is See Remark of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 237,628 shares of AQST, which is worth approximately $1.12 Million. The most recent transaction as insider was on Mar 09, 2024, when has been sold 8,370 shares (Common Stock) at a price of $4.88 per share, resulting in proceeds of $40,845. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 238K
0% 3M change
48.95% 12M change
Total Value Held $1.12 Million

Peter E. Boyd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 09 2024
SELL
Payment of exercise price or tax liability
$40,845 $4.88 p/Share
8,370 Reduced 3.4%
237,628 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
86,250 Added 25.96%
245,998 Common Stock
Mar 09 2023
BUY
Grant, award, or other acquisition
-
100,000 Added 38.53%
159,532 Common Stock
Jun 14 2022
BUY
Open market or private purchase
$4,050 $0.81 p/Share
5,000 Added 7.75%
59,532 Common Stock
Jun 08 2022
BUY
Open market or private purchase
$2,201 $0.96 p/Share
2,293 Added 4.04%
54,532 Common Stock
PEB

Peter E. Boyd

See Remark
Warren, NJ

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Track Activities on AQST